PWA
GILD icon

Phoenix Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Phoenix Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-591
Closed -$41K – 211
2021
Q3 		$41K Hold
591
– – 0.03% 201
2021
Q2 		$40K Sell
591
-152
-20% -$10.2K 0.03% 202
2021
Q1 		$49K Hold
743
– – 0.04% 189
2020
Q4 		$43K Buy
+743
New +$44.8K 0.03% 200

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Phoenix Wealth Advisors's GILD Position: Q4 2021 in Review

Phoenix Wealth Advisors sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 591 shares — an estimated $41K sold.

Phoenix Wealth Advisors first reported a position in GILD in Q4 2020 and held it in 4 quarters. The position peaked at $49K in Q1 2021. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Phoenix Wealth Advisors reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Phoenix Wealth Advisors sold 591 Gilead Sciences shares in Q4 2021, an estimated $41K.
  • Phoenix Wealth Advisors first reported a position in Gilead Sciences in Q4 2020 and held it in 4 quarters.
  • Phoenix Wealth Advisors's Gilead Sciences position peaked at $49K in Q1 2021.
  • 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Phoenix Wealth Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.